Stock 1801 INNOVENT BIOLOGICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Innovent Biologics, Inc.

Equities

1801

KYG4818G1010

Delayed Hong Kong S.E.
Other stock markets
 10:45:03 2024-06-03 pm EDT 		5-day change 1st Jan Change
35.95 HKD +4.51% Intraday chart for Innovent Biologics, Inc. -2.58% -16.14%
Jun. 02 Innovent Biologics, Inc. Presents at 2024 ASCO Annual Meeting on Clinical Data of Anti-CLDN18.2 ADC in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer CI
Jun. 02 Innovent Biologics, Inc. Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib (ROS1 Inhibitor) Publishes in JCO and Reports at 2024 ASCO Annual Meeting CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
 7.32B -
CSL LIMITED Stock CSL Limited
 89.87B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
 37.57B
BIOGEN INC. Stock Biogen Inc.
 32.75B
UCB Stock UCB
 26.47B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
 14.25B
  1. Stock Market
  2. Equities
  3. 1801 Stock
  4. Charts Innovent Biologics, Inc.
  5. Sector Chart